Gendiag.exe, S.l.

Genincode Plc

Roberto Elosua Llanos

Sergio Castillo Fernandez

Jaume Marrugat De La Iglesia

Eduardo Salas Perez-Rasilla

Joan Vila

José Manuel Soria

Eduardo Salas

Miroslava Ogorelkova

Joan Salgado Gómez

Joan Salgado Gomez

Sergio Castillo

Jose Maria Ordovás Munoz

Eduardo Salas Pérez-Rasilla

José Maria Ordovás Munoz

Marta Carrera

Matthew Heaton Walls

Jose Maria Ordovas Munoz

Eduardo Salas PÉREZ-Rasilla

Joan Salgado GÓMEZ

Sergio Castillo FERNÁNDEZ

José Maria ORDOVÁS Munoz

José María Ordovás Muñoz

The invention relates to a method for the reclassification of a subject to a more appropriate risk assessment to that obtained using the algorithms for such risk estimation such us but not limited to Framingham, Regicor, Score, Procam or Qrisk based on the presence of different polymorphisms. The invention also relates to a method for determining the risk of suffering a cardiovascular disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for CVD as well as computer-implemented methods for carrying out the risk determination.

Risk assessment for cardiovascular disease

The invention relates to a method for the reclassification of a subject to a more appropriate risk assessment to that obtained using the algorithms for such risk estimation such us but not limited to Framingham, Regicor, Score, Procamor Qrisk based on the presence of different polymorphisms. The invention also relates to a method for determining the risk of suffering a cardiovascular disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for CVD as well as computer-implemented means for carrying out said method.

Cardiovascular disease

The invention relates to a method for a more appropriate thromboembolic event risk assessment based on the presence of different genetic variant. The invention also relates to a method for determining the risk of suffering a thromboembolism disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for thromboembolism as well as computer-implemented means for carrying out said method.

Thromboembolic disease markers

The invention relates to a method for determining the risk of suffering a cardiovascular disease based on the presence of different polymorphisms as well as to kits for practicing the above method. The invention also relates to a method for determining the risk of suffering a cardiovascular disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for CVD as well as computer-implemented means for carrying out said method.

Method for detecting polymorphisms

Growing community of inventors

Barcelona, Spain

Roberto Elosua Llanos